HUMIRA PEN 40 MG/0.8 ML

Adalimumab
$3366.5900per EA

Manufacturer

AbbVie Inc.

NDC

00074433902

Classification

Brand

Dosage Form

KIT

Last Updated

4/22/2026

Approval Type

Biologic (BLA)

FDA Application

BLA125057

On Market Since

6/23/2006

Price History

1W

0.0%

1M

+0.0%

3M

+0.0%

6M

+0.0%

1Y

+0.1%

3Y

-0.1%

5Y

+15.9%

All

+193.3%

Generic Alternatives

Save up to 0%

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.